Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine versus povidone-iodine for prevention of pin site infection in tibial external fixation
PACTR202212494403386Completed
- Sponsor
- Dr. Gbenga Jones
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in tibia fracture comparing 5% chlorhexidine with 10% povidone-iodine (2 arms). Primary endpoint: Incidence of pin site infection. Started Oct 2020; status: completed.
02
Drugs
chlorhexidinepovidone-iodine
03
Conditions
tibia fracture
Beyond the preview
Go deeper on PACTR202212494403386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202212494403386.